oxamic acid has been researched along with oxamide in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (37.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (20.83) | 29.6817 |
| 2010's | 20 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakie, C; Watanakunakorn, C | 1 |
| Amsterdamsky, C; Hetzel, FW; McMahon, JD; O'Hara, MD; Phillip, MJ; Schaap, AP | 1 |
| Frith, CH; Jackson, CD; Stanley, JW; West, RW | 2 |
| Diasamidze, IA; Vadachkoriia, GA | 1 |
| Barsukov, NP; Fomochkin, IP; Gasymova, LP; Sapegin, DI; Svistov, VV | 1 |
| Finlayson, B; Hackett, RL; Khan, SR; Konicek, JR | 1 |
| Liu, L; Nussbaum, MA; Olsen, BA; Yang, L | 1 |
| Fowler, FW; Lauher, JW; Nguyen, TL | 1 |
| Alemán, C; Armelin, E; Puiggalí, J | 1 |
| Chohan, ZH; Farooq, MA; Scozzafava, A; Supuran, CT | 1 |
| Paradowska, K; Rowińska, M; Temeriusz, A; Wawer, I | 1 |
| CONRAD, WE | 1 |
| ARNOLD, A; KIRCHNER, FK; SORIA, AE | 1 |
| ARNOLD, A; HOWARD, JW; KARCZMAR, AG; LANDS, AM | 1 |
| KARCZMAR, AG | 1 |
| ALAJOUANINE, T; BOURGUIGNON, A; CAMBIER, J; CASTAIGNE, P | 1 |
| GENTILI, C; LOPERFIDO, E | 1 |
| GILL, WB; VERMEULEN, CW | 1 |
| HARKNESS, DR; STADTMAN, ER; TSAI, L | 1 |
| BLABER, LC; KARCZMAR, AG; KIM, KC | 1 |
| MARSHALL, CK; SCHWAB, RS; TIMBERLAKE, W | 1 |
| HARGREAVES, AB; LEMME, CC; SOLLERO, L | 1 |
| Furukawa, J; Hinou, H; Kita, Y; Kuramoto, H; Kurogochi, M; Miura, Y; Nishimura, S; Shimaoka, H; Shinohara, Y | 1 |
| Cheng, P; Jiang, ZH; Liao, DZ; Mibu, K; Xu, N; Yan, SP; Yoshimura, K; Zhang, W; Zhu, LN | 1 |
| Arunkumar, P; Kandaswamy, M; Krishnapriya, KR; Saravanakumar, D | 1 |
| Gavrish, SP; Lampeka, YD; Lightfoot, P; Pritzkow, H | 1 |
| He, RX; Huang, CZ; Li, YF; Long, YF | 1 |
| Gimisis, T | 1 |
| Jeon, Y; Khang, G; Kim, B; Kwon, J; Lee, D; Song, Y | 1 |
| Ghodke, M; Girbane, A; Nikalje, AP | 1 |
| Li, XW; Li, YT; Tao, L; Wu, ZY; Yan, CW | 1 |
| Li, XJ; Li, XW; Li, YT; Wu, ZY; Yan, CW | 1 |
| Gao, Y; Li, YT; Wu, ZY; Yan, CW | 1 |
| Li, XJ; Li, YT; Wang, LD; Wu, ZY; Yan, CW; Zheng, K | 1 |
| Jiang, M; Jiao, J; Li, YT; Wu, ZY; Yan, CW | 1 |
| Jelić, RM; Klisurić, OR; Matović, ZD; Mrkalić, EM | 1 |
| Chen, N; Xie, J | 2 |
| Li, YT; Liu, F; Wu, ZY; Yan, CW; Zhao, FJ; Zhao, HQ | 1 |
| Li, YT; Wu, ZY; Yan, CW; Zheng, K; Zhu, L | 2 |
| Carfagna, C; Della Ca', N; Fini, F; Gabriele, B; Mancuso, R; Raut, DS | 1 |
| Manimaran, B; Nagarajaprakash, R; Ramakrishna, B; Sakthivel, N; Veena, V | 1 |
| Cross, B; Duan, Y; Gonzales, SS; Hanson, JM; Lemoff, A; McKnight, JS; Mirzaei, H; Moreno, JR; Morlock, LK; Nijhawan, D; Owen, AE; Posner, BA; Ready, JM; Rodriguez-Navas, C; Theodoropoulos, PC; Williams, NS; Winterton, SE | 1 |
| Fu, HL; Li, YT; Wu, ZY; Yan, CW; Zhang, MJ; Zheng, K | 1 |
| Anjum, DH; Croissant, JG; Emwas, AH; Fatieiev, Y; Julfakyan, K; Khashab, NM; Lu, J; Omar, H; Tamanoi, F; Zink, JI | 1 |
| Fazal-Ur-Rehman, S; Iqbal, L; Iqbal, S; Khan, MA; Lateef, M; Wasim, AA | 1 |
1 review(s) available for oxamic acid and oxamide
| Article | Year |
|---|---|
Synthesis of N-glucopyranosidic derivatives as potential inhibitors that bind at the catalytic site of glycogen phosphorylase.
Topics: Catalytic Domain; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucose; Glycogen Phosphorylase; Humans; Hypoglycemic Agents; Nucleosides; Oxamic Acid; Peptides; Spiro Compounds | 2010 |
47 other study(ies) available for oxamic acid and oxamide
| Article | Year |
|---|---|
Pathogenicity of stable L-phase variants of Staphylococcus aureus: failure to colonize normal and oxamide-induced hydronephrotic renal medulla of rats.
Topics: Amides; Animals; Hydronephrosis; Kidney Medulla; L Forms; Male; Oxalates; Oxamic Acid; Rats; Staphylococcus; Urine | 1974 |
Effects of hematoporphyrin (HPD) and a chemiluminescence system on the growth of transplanted tumors in C3H/HeJ mice.
Topics: Animals; Female; Hematoporphyrin Derivative; Hematoporphyrins; Luminescent Measurements; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Naphthacenes; Neoplasm Transplantation; Oxamic Acid; Photochemotherapy | 1984 |
The role of urinary physiological changes in the genesis of urothelial lesions in mice given 4-ethylsulfonylnaphthalene-1-sulfonamide, acetazolamide, and oxamide.
Topics: Acetazolamide; Amino Acids; Animals; Crystallization; Diet; Dose-Response Relationship, Drug; Epithelium; Female; Hydrogen-Ion Concentration; Hyperplasia; Mice; Mice, Inbred BALB C; Naphthalenes; Osmolar Concentration; Oxamic Acid; Proteinuria; Urologic Diseases | 1984 |
Urothelial lesions in mice given 4-ethylsulfonylnaphthalene-1-sulfonamide, acetazolamide, and oxamide.
Topics: Acetazolamide; Amino Acids; Animals; Epithelium; Female; Hyperplasia; Male; Mice; Mice, Inbred BALB C; Naphthalenes; Oxamic Acid; Ureter; Urethra; Urinary Bladder; Urologic Diseases | 1984 |
[Role of the neurosecretion of the supraoptic and paraventricular hypothalamic nuclei in the pathogenesis of experimental urolithiasis].
Topics: Animals; Male; Neurosecretion; Oxamic Acid; Paraventricular Hypothalamic Nucleus; Rats; Supraoptic Nucleus; Time Factors; Urinary Calculi | 1983 |
[Establishment of the maximum permissible concentration for oxamide in reservoir water].
Topics: Amino Acids; Animals; Dose-Response Relationship, Drug; Female; Lethal Dose 50; Male; Maximum Allowable Concentration; Mice; Oxamic Acid; Rats; Surface-Active Agents; Time Factors; Water Pollutants; Water Pollutants, Chemical | 1982 |
Light and scanning electron microscopic studies of oxamide urolithiasis in rats.
Topics: Amino Acids; Animals; Crystallization; Kidney; Male; Microscopy, Electron, Scanning; Oxamic Acid; Rats; Rats, Inbred Strains; Urinary Calculi | 1981 |
The determination of oxalic acid, oxamic acid, and oxamide in a drug substance by ion-exclusion chromatography.
Topics: Chromatography, Gel; Chromatography, High Pressure Liquid; Drug Contamination; Linear Models; Oxalic Acid; Oxamic Acid; Reducing Agents; Sensitivity and Specificity | 2000 |
Commensurate and incommensurate hydrogen bonds. An exercise in crystal engineering.
Topics: Crystallization; Glycine; Hydrogen Bonding; Models, Molecular; Oxamic Acid; Pyridines; Urea | 2001 |
Structural versatility of oxalamide-based compounds: a computational study on the isomerization of the oxalamide group and the structural preferences of the polyoxalamides.
Topics: Crystallization; Hydrogen Bonding; Isomerism; Models, Molecular; Molecular Conformation; Monte Carlo Method; Oxamic Acid; Polymers | 2001 |
Antibacterial Schiff bases of oxalyl-hydrazine/diamide incorporating pyrrolyl and salicylyl moieties and of their zinc(II) complexes.
Topics: Aldehydes; Anti-Bacterial Agents; Bacteria; Microbial Sensitivity Tests; Organometallic Compounds; Oxalates; Oxamic Acid; Pyrroles; Schiff Bases; Structure-Activity Relationship; Zinc | 2002 |
Synthesis and solid state 13C and 1H NMR analysis of new oxamide derivatives of methyl 2-amino-2-deoxy-alpha-D-glucopyranoside and ester of amino acids or dipeptides.
Topics: Amino Acids; Carbon Isotopes; Dipeptides; Glucosides; Glycoconjugates; Magnetic Resonance Spectroscopy; Oxamic Acid; Protons | 2003 |
The isolation of oxamide and parabanic acid from the products of ultraviolet irradiated uracil.
Topics: Hydantoins; Imidazoles; Oxalates; Oxamic Acid; Ultraviolet Rays; Uracil | 1954 |
A new anticholinesterase oxamide.
Topics: Cholinesterase Inhibitors; Oxamic Acid | 1954 |
An evaluation of the pharmacologic actions of some bis-quaternary salts of basically substituted oxamides (WIN 8077 and analogs).
Topics: Oxamic Acid; Parasympathomimetics; Salts | 1955 |
Antagonism between a bis-quaternary oxamide, Win 8078, and depolarizing and competitive blocking agents.
Topics: Cardiovascular Agents; Humans; Muscle Relaxants, Central; Oxamic Acid; Parasympathomimetics | 1957 |
[Clinical trials with a new anti-myasthenic drug: N, N'-bis (2-diethylaminoethyl)-oxamide bis-2-chlorobenzyl chloride (Win 8077)].
Topics: Benzyl Compounds; Chlorides; Myasthenia Gravis; Oxamic Acid; Parasympathomimetics | 1958 |
[On anti-myasthenic activity of an oxamide derivative (Win 8077)].
Topics: Ambenonium Chloride; Myasthenia Gravis; Oxamic Acid; Parasympathomimetics | 1959 |
OXAMIDE CRYSTALLURIA AND UROLITHIASIS, RAT AND IN VITRO OBSERVATIONS.
Topics: Amides; In Vitro Techniques; Oxalates; Oxamic Acid; Pharmacology; Photomicrography; Rats; Research; Surgical Procedures, Operative; Urinary Calculi; Urolithiasis; Urologic Diseases | 1964 |
BACTERIAL DEGRADATION OF RIBOFLAVIN. V. STOICHIOMETRY OF RIBOFLAVIN DEGRADATION TO OXAMIDE AND OTHER PRODUCTS, OXIDATION OF C14-LABELED INTERMEDIATES AND ISOLATION OF THE PSEUDOMONAD EFFECTING THESE TRANSFORMATIONS.
Topics: Amides; Amino Acids; Carbon Dioxide; Carbon Isotopes; Chromatography; Lipids; Metabolism; Oxamic Acid; Oxidation-Reduction; Pseudomonas; Pyrans; Riboflavin; Urea; Xylenes | 1964 |
PHARMACOLOGICAL ACTIONS OF OXAMIDES AND HYDROXYANILINIUM COMPOUNDS AT FROG NEUROMYAL JUNCTION.
Topics: Acetylcholine; Amides; Aniline Compounds; Animals; Anura; Neostigmine; Neural Conduction; Neuromuscular Junction; Oxamic Acid; Pharmacology; Physostigmine; Research; Tubocurarine | 1965 |
WIN 8077 in treatment of myasthenia gravis; use of N,N'-bis (2-diethylaminoethyl) oxamide bis-2-chlorobenzyl chloride in fifty patients.
Topics: Ambenonium Chloride; Benzyl Compounds; Ions; Myasthenia Gravis; Oxamic Acid; Parasympathomimetics | 1955 |
In vitro activity of NN'-bis(diethylaminoethyl) oxamide bis benzyl-chloride (mytelase) on the cholinesterase of the electric organ of Electrophorus electricus, L.
Topics: Ambenonium Chloride; Animals; Benzyl Compounds; Cholinesterase Inhibitors; Eels; Electric Organ; Electrophorus; In Vitro Techniques; Oxamic Acid; Parasympathomimetics | 1959 |
One-pot solid-phase glycoblotting and probing by transoximization for high-throughput glycomics and glycoproteomics.
Topics: Acrylamides; Aldehydes; Amino Acid Sequence; Chromatography, High Pressure Liquid; Electrophoresis, Capillary; Galactose Oxidase; Glycopeptides; Glycosylation; Humans; Hydrogen-Ion Concentration; Ketones; Mass Spectrometry; Molecular Sequence Data; Oxamic Acid; Oximes; Polysaccharides; Proteomics | 2007 |
Heteronuclear complexes of macrocyclic oxamide with co-ligands: syntheses, crystal structures, and magnetic properties.
Topics: Copper; Crystallography, X-Ray; Iron; Ligands; Macrocyclic Compounds; Magnetics; Manganese; Molecular Structure; Organometallic Compounds; Oxamic Acid; Spectrophotometry, Infrared; Temperature; Zinc | 2007 |
Synthesis of new oxamide-based ligand and its coordination behavior towards copper(II) ion: spectral and electrochemical studies.
Topics: Copper; Electrochemistry; Electron Spin Resonance Spectroscopy; Ligands; Magnetics; Mass Spectrometry; Oxamic Acid; Spectrum Analysis | 2008 |
Crystal and molecular structures of related nickel(II) complexes of open-chain and macrocyclic oxamide-based ligands and the peculiarities of water aggregates in their crystal lattices.
Topics: Crystallography, X-Ray; Electrochemistry; Ligands; Macrocyclic Compounds; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Nickel; Organometallic Compounds; Oxamic Acid; Water | 2007 |
Selectively light scattering spectrometric detection of copper (II) based on a new synthesized oxamide ligand.
Topics: Copper; Ligands; Light; Oxamic Acid; Scattering, Radiation; Spectrometry, Fluorescence; Spectrophotometry, Atomic; Water | 2008 |
Physicobiological properties and biocompatibility of biodegradable poly(oxalate-co-oxamide).
Topics: Animals; Biocompatible Materials; Cell Line; Implants, Experimental; Lactic Acid; Macrophages; Materials Testing; Mice; Molecular Structure; Oxalates; Oxamic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar | 2011 |
Design and synthesis of novel diphenyl oxalamide and diphenyl acetamide derivatives as anticonvulsants.
Topics: Acetamides; Animals; Anticonvulsants; Behavior, Animal; Diphenylacetic Acids; Dose-Response Relationship, Drug; Drug Design; Female; Male; Mice; Molecular Structure; Motor Activity; Neurotoxicity Syndromes; Oxamic Acid; Seizures; Structure-Activity Relationship | 2012 |
Bimetallic complexes constructed from asymmetrical N,N'-bis(substituted)-oxamide: cytotoxicities, and reactivities towards DNA and protein.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Line, Tumor; DNA; Humans; Ligands; Organometallic Compounds; Oxamic Acid; Serum Albumin, Bovine | 2012 |
Syntheses and structures of new trimetallic complexes bridged by N-(5-chloro-2-hydroxyphenyl)-N'-[3-(dimethylamino)propyl]oxamide: cytotoxic activities, and reactivities towards DNA and protein.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Copper; Dimethylamines; DNA; Humans; Liver Neoplasms; Lung Neoplasms; Nickel; Organometallic Compounds; Oxamic Acid; Protein Binding; Serum Albumin, Bovine | 2013 |
Synthesis and crystal structure of binuclear copper(II) complex bridged by N-(2-hydroxyphenyl)-N'-[3-(diethylamino)propyl]oxamide: in vitro anticancer activity and reactivity toward DNA and protein.
Topics: Animals; Cattle; Cell Line, Tumor; Coordination Complexes; Copper; Crystallography, X-Ray; DNA; Humans; Hydrogen Bonding; Molecular Structure; Oxamic Acid; Serum Albumin, Bovine | 2013 |
Syntheses and crystal structures of tetracopper(II) complexes bridged by asymmetric N,N'-bis(substituted)oxamides: Molecular docking, DNA-binding and in vitro anticancer activity.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Survival; Coordination Complexes; Copper; Crystallography, X-Ray; DNA; Humans; Hydrogen Bonding; Inhibitory Concentration 50; Models, Chemical; Models, Molecular; Molecular Structure; Nucleic Acid Conformation; Oxamic Acid; Phenanthrolines | 2013 |
In vitro cytotoxic activities, DNA-, and BSA-binding studies of a new dinuclear copper(II) complex with N-[3-(dimethylamino)propyl]-N'-(2-carboxylatophenyl)-oxamide as ligand.
Topics: Animals; Antineoplastic Agents; Binding Sites; Cattle; Cell Death; Cell Line, Tumor; Coordination Complexes; Copper; Crystallography, X-Ray; DNA; Electrochemical Techniques; Humans; Hydrogen Bonding; Ligands; Models, Molecular; Oxamic Acid; Protein Binding; Rhodamines; Serum Albumin, Bovine; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Viscosity | 2014 |
Synthesis of novel palladium(II) complexes with oxalic acid diamide derivatives and their interaction with nucleosides and proteins. Structural, solution, and computational study.
Topics: Coordination Complexes; Crystallography, X-Ray; DNA; Endoplasmic Reticulum Chaperone BiP; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; Molecular Docking Simulation; Nucleosides; Oxamic Acid; Palladium; Serum Albumin | 2014 |
Synthesis of N-oxyamide-linked neoglycolipids.
Topics: Glycolipids; Glycosphingolipids; Hydrogen Bonding; Molecular Structure; Oxamic Acid | 2014 |
Synthesis and crystal structure of new dicopper(II) complexes with N,N'-bis-(dipropylenetriamine)oxamide as bridging ligand: effects of the counterions on DNA/protein-binding property and in vitro antitumor activity.
Topics: Animals; Antineoplastic Agents; Binding Sites; Cattle; Cell Line, Tumor; Chemistry Techniques, Synthetic; Copper; Crystallography, X-Ray; DNA; Humans; Intercalating Agents; Ligands; Models, Molecular; Molecular Conformation; Organometallic Compounds; Oxamic Acid; Serum Albumin, Bovine; Viscosity | 2015 |
Synthesis and crystal structure of new dicopper(II) complexes having asymmetric N,N'-bis(substituted)oxamides with DNA/protein binding ability: In vitro anticancer activity and molecular docking studies.
Topics: Animals; Antineoplastic Agents; Base Sequence; Binding Sites; Cattle; Cell Line, Tumor; Chemistry Techniques, Synthetic; Coordination Complexes; Copper; Crystallography, X-Ray; DNA; Molecular Docking Simulation; Nucleic Acid Conformation; Oxamic Acid; Protein Binding; Protein Conformation; Serum Albumin, Bovine; Viscosity | 2015 |
Catalytic Oxidative Carbonylation of Amino Moieties to Ureas, Oxamides, 2-Oxazolidinones, and Benzoxazolones.
Topics: Amines; Amino Alcohols; Aminophenols; Benzoxazoles; Catalysis; Imidazoles; Ionic Liquids; Oxamic Acid; Oxazolidinones; Oxidation-Reduction; Palladium; Urea | 2015 |
Self-assembly of oxamidato bridged ester functionalised dirhenium metallastirrups: synthesis, characterisation and cytotoxicity studies.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; Esters; Humans; Models, Molecular; Molecular Conformation; Organometallic Compounds; Oxamic Acid; Rhenium | 2015 |
Synthesis of glycoaminooxy acid and N-oxyamide-linked glycolipids.
Topics: Carbohydrate Conformation; Glycolipids; Glycosides; Oxamic Acid | 2016 |
Synthesis and structure elucidation of new μ-oxamido-bridged dicopper(II) complex with in vitro anticancer activity: A combined study from experiment verification and docking calculation on DNA/protein-binding property.
Topics: Animals; Antineoplastic Agents; Binding Sites; Cattle; Cell Line, Tumor; Cell Survival; Coordination Complexes; Copper; Crystallography, X-Ray; DNA; Hep G2 Cells; Humans; Hydrogen Bonding; Molecular Conformation; Molecular Docking Simulation; Nucleic Acid Conformation; Oxamic Acid; Protein Structure, Tertiary; Serum Albumin, Bovine; Spectrometry, Fluorescence | 2016 |
Discovery of tumor-specific irreversible inhibitors of stearoyl CoA desaturase.
Topics: Animals; Antineoplastic Agents; Benzothiazoles; Cell Line, Tumor; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Drug Discovery; Female; Humans; Lung Neoplasms; Male; Mice; Mice, SCID; Molecular Structure; Molecular Targeted Therapy; Oxamic Acid; Protein Binding; Sebaceous Glands; Stearoyl-CoA Desaturase; Xenograft Model Antitumor Assays | 2016 |
Synthesis and structure of new tetracopper(II) complexes with N-benzoate-N'-[3-(diethylamino)propyl]oxamide as a bridging ligand: The influence of hydrophobicity on enhanced DNA/BSA-binding and anticancer activity.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Benzoates; Binding Sites; Cell Line, Tumor; Coordination Complexes; Copper; Crystallography, X-Ray; DNA; Electrochemical Techniques; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Molecular Conformation; Oxamic Acid; Serum Albumin, Bovine; Spectrometry, Fluorescence; Spectrophotometry, Infrared | 2016 |
Biodegradable Oxamide-Phenylene-Based Mesoporous Organosilica Nanoparticles with Unprecedented Drug Payloads for Delivery in Cells.
Topics: Drug Delivery Systems; Hydrophobic and Hydrophilic Interactions; Nanoparticles; Organosilicon Compounds; Oxamic Acid; Silicon Dioxide | 2016 |
Synthesis, lipoxygenase inhibition activity and molecular docking of oxamide derivative.
Topics: Amines; Arachidonate 5-Lipoxygenase; Chlorides; Drug Evaluation, Preclinical; Lipoxygenase Inhibitors; Magnetic Resonance Spectroscopy; Molecular Docking Simulation; Oxalates; Oxamic Acid; Protein Conformation; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2019 |